This history of US-led international drug control provides new perspectives on the economic, ideological, and political foundations of a Cold War American empire. US officials assumed the helm of international drug control after World War II at a moment of unprecedented geopolitical influence embodied in the growing economic clout of its pharmaceutical industry. We Sell Drugs is a study grounded in the transnational geography and political economy of the coca-leaf and coca-derived commodities market stretching from Peru and Bolivia into the United States. More than a narrow biography of one famous plant and its equally famous derivative products—Coca-Cola and cocaine—this book situates these commodities within the larger landscape of drug production and consumption. Examining efforts to control the circuits through which coca traveled, Suzanna Reiss provides a geographic and legal basis for considering the historical construction of designations of legality and illegality. The book also argues that the legal status of any given drug is largely premised on who grew, manufactured, distributed, and consumed it and not on the qualities of the drug itself. Drug control is a powerful tool for ordering international trade, national economies, and society’s habits and daily lives. In a historical landscape animated by struggles over political economy, national autonomy, hegemony, and racial equality, We Sell Drugs insists on the socio-historical underpinnings of designations of legality to explore how drug control became a major weapon in asserting control of domestic and international affairs.

This history of US-led international drug control provides new perspectives on the economic, ideological, and political foundations of a Cold War American empire. US officials assumed the helm of international drug control after World War II at a moment of unprecedented geopolitical influence embodied in the growing economic clout of its pharmaceutical industry. We Sell Drugs is a study grounded in the transnational geography and political economy of the coca-leaf and coca-derived commodities market stretching from Peru and Bolivia into the United States. More than a narrow biography of one famous plant and its equally famous derivative products—Coca-Cola and cocaine—this book situates these commodities within the larger landscape of drug production and consumption. Examining efforts to control the circuits through which coca traveled, Suzanna Reiss provides a geographic and legal basis for considering the historical construction of designations of legality and illegality. The book also argues that the legal status of any given drug is largely premised on who grew, manufactured, distributed, and consumed it and not on the qualities of the drug itself. Drug control is a powerful tool for ordering international trade, national economies, and society’s habits and daily lives. In a historical landscape animated by struggles over political economy, national autonomy, hegemony, and racial equality, We Sell Drugs insists on the socio-historical underpinnings of designations of legality to explore how drug control became a major weapon in asserting control of domestic and international affairs.

Jamie Reidy is the guy who's been there, done that, and walked away with the insider stories. Inside Hard Sell: Now a Major Motion Picture LOVE and OTHER DRUGS, you'll find yourself rooting for Reidy and shocked by the realities of the world that paid his salary. This comedic expose traces Reidy's experiences from Pfizer training to life as the "V-Man," when Reidy became Pfizer's number-one drug rep during the Viagra craze. With equal parts self-confidence and self-mockery, Reidy takes the reader on a hilarious romp through pharma-culture while revealing the controversial side of the drug industry. From viewing a circumcision to gaining a doctor's rapport to providing insight on why doctors choose to prescribe Drug X over Drug Y, and from how to bargain "sigs" and "scripts" to why the Viagra pill is shaped as a diamond, Reidy discloses everything. A witty, behind-the-scenes look at an industry that touches everyone in America with a prescription, Hard Sell uncovers truths about the pharmaceutical industry you'd rather not know and practices you'd like to believe weren't employed. Hard Sell has been adapted into a major motion picture starring Jake Gyllenhaal and Anne Hathaway.

Over the last fifteen years, American taxpayers have spent over $300 billion to wage the war on drugs--three times what it cost to put a man on the moon. In Drug Crazy, journalist Mike Gray offers a scathing indictment of this financial fiasco, chronicling a series of expensive and hypocritical follies that have benefited only two groups: professional anti-drug advocates and drug lords. The facts are alarming. More than twenty-five years ago, a presidential committee determined that marijuana is neither an addictive substance nor a "stepping stone" to harder drugs, but the embarrassing final report was shelved by a government already heavily invested in "the war against drugs". Many medical experts recommend simply prescribing drugs to addicts, and communities that have done this report a lower crime rate and reduced unemployment among drug users. In a riveting account of how we got to this impasse--discriminatory policies, demonization of users, grandstanding among both lawmakers and lawbreakers--conventional wisdom is turned on its head. Rather than a planned assault on the scourge of addiction, the drug war has happened almost by accident and has been continually exploited by political opportunists. A gripping account of the violence, corruption, and chaos characterizing the drug war since its inception, Mike Gray's incisive narrative launches a frontal attack on America's drug orthodoxy. His overview of the battlefield makes it clear that this urgent debate must begin now.

The Business Secrets of Drug Dealing tells the story of a hyper-observant, politically-minded, but humorously pragmatic weed dealer who has spent a working life compiling rules for how to a) make money and b) avoid prison. Each rule shapes a chapter of this fast-paced outlaw tale, all delivered in Huey Carmichael's deliciously trenchant argot. Here are a few of them: No guns but keep shooters. Stay behind the white guy. Don't snitch. Always have a job. Be multi-sourced. Get your money and get out. Part edge-of-the-seat suspense story, part how-to manual in the tradition of The Anarchist Cookbook, The Business Secrets of Drug Dealing is as scintillating as it is subversive. Just reading it feels illegal.

“A beautiful and well-researched historical guide to significant drugs” from the author of The Complete Idiot’s Guide to Prescription Drugs (Library Journal). Throughout history, humans everywhere have searched for remedies to heal our bodies and minds. Covering everything from ancient herbs to cutting-edge chemicals, this book in the hugely popular Milestones series looks at 250 of the most important moments in the development of life-altering, life-saving, and sometimes life-endangering pharmaceuticals. Illustrated entries feature ancient drugs like alcohol, opium, and hemlock; the smallpox and the polio vaccines; homeopathic cures; and controversial medical treatments like ether, amphetamines, and Xanax—while shining a light on the scientists, doctors, and companies who brought them to us. “These true tales of discovery in The Drug Book by Michael C. Gerald might change the way you think about your medicine.” —The Healthy “An excellent starting point for student researchers and is very browsable for the general reader.” —Booklist

The inside story of a band of entrepreneurial upstarts who made millions selling painkillers—until their scheme unraveled, putting them at the center of a landmark criminal trial. • SOON TO BE THE MAJOR MOTION PICTURE PAIN HUSTLERS STARRING EMILY BLUNT AND CHRIS EVANS "Unfolds with the velocity and verve of a Scorsese film…A tour de force."—Patrick Radden Keefe, New York Times bestselling author of Empire of Pain and Say Nothing John Kapoor had already amassed a small fortune in pharmaceuticals when he founded Insys Therapeutics. It was the early 2000s, a boom time for painkillers, and he developed a novel formulation of fentanyl, the most potent opioid on the market. Kapoor, a brilliant immigrant scientist with relentless business instincts, was eager to make the most of his innovation. He gathered around him an ambitious group of young lieutenants. His head of sales—an unstable and unmanageable leader, but a genius of persuasion—built a team willing to pull every lever to close a sale, going so far as to recruit an exotic dancer ready to scrape her way up. They zeroed in on the eccentric and suspect doctors receptive to their methods. Employees at headquarters did their part by deceiving insurance companies. The drug was a niche product, approved only for cancer patients in dire condition, but the company’s leadership pushed it more widely, and together they turned Insys into a Wall Street sensation. But several insiders reached their breaking point and blew the whistle. They sparked a sprawling investigation that would lead to a dramatic courtroom battle, breaking new ground in the government’s fight to hold the drug industry accountable in the spread of addictive opioids. In The Hard Sell, National Magazine Award–finalist Evan Hughes lays bare the pharma playbook. He draws on unprecedented access to insiders of the Insys saga, from top executives to foot soldiers, from the patients and staff of far-flung clinics to the Boston investigators who treated the case as a drug-trafficking conspiracy, flipping cooperators and closing in on the key players. With colorful characters and true suspense, The Hard Sell offers a bracing look not just at Insys, but at how opioids are sold at the point they first enter the national bloodstream—in the doctor’s office.